Innovative radiotherapy offers a precision treatment alternative.

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

Thermo Fisher Scientific has joined forces with Labguru to integrate Labguru’s Electronic Lab Notebook (ELN) into Thermo Fisher’s Laboratory Information Management System (LIMS) and lab operations ...

Advances in medicinal chemistry are driving the development of more sophisticated compounds, often with highly targeted mechanisms of action. These innovations, while promising, are also pushing the ...

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% ...

At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the ...

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% increase in therapy initiation, driven by AI-enabled patient outreach and ...